Metabolic Optimization Peptide
Growth Hormone
Targets visceral fat reduction through natural growth hormone stimulation.
$229 / month
Starting at $175/mo with 3-month supply + WELCOME10
About
Tesamorelin is a stabilized growth-hormone-releasing-hormone (GHRH) analog — it signals your own pituitary to release a natural pulse of growth hormone, rather than injecting GH directly. It is the only peptide in its class with FDA approval (for HIV-associated lipodystrophy), studied across multiple Phase III trials.
What sets it apart is where the fat loss happens: tesamorelin drives lipolysis specifically in visceral adipose tissue — the deep belly fat that wraps around your organs and drives metabolic disease — while sparing subcutaneous fat and lean muscle. In trials that meant roughly a 15% reduction in visceral fat over 26 weeks, alongside improved triglyceride levels.
PeRx ships Tesamorelin fully reconstituted from an FDA-registered 503A pharmacy. No mixing — insulin syringes and a step-by-step guide arrive in the box. It is a single daily subcutaneous injection on a provider-determined schedule.
Reduces visceral fat by up to 15% while preserving lean muscle mass and strength.
Shifts the balance from fat storage to fat burning, improving overall body composition.
Energy and endurance return as growth hormone climbs back to where it was a decade ago.
Growth hormone peaks at night. Better sleep quality follows when those nighttime pulses are working properly.
Lipid profiles and triglyceride levels improve alongside the fat loss. The whole metabolic picture shifts.
Why people explore Tesamorelin
Visceral fat isn't the fat you can pinch — it's the deep abdominal fat around your organs that's tied to metabolic disease. Tesamorelin promotes fat breakdown specifically there, sparing subcutaneous fat and lean mass.
~15% visceral fat reduction over 26 weeks in Phase III trials.
Tesamorelin doesn't replace growth hormone — it asks your pituitary to make more of its own, in the natural pulsatile pattern. That preserves the feedback loop and avoids the risks of flat, supraphysiologic dosing.
Beyond the waistline, tesamorelin has been shown to improve triglyceride and lipid levels without disrupting glucose metabolism — so the change shows up on bloodwork, not just in the mirror.
What it helps with
Ideal for
Those seeking targeted fat reduction · Individuals with stubborn abdominal fat · Those looking to improve metabolic health · Adults seeking body composition optimization
The science
Tesamorelin works by binding to growth hormone-releasing hormone receptors in the pituitary gland, triggering the natural release of growth hormone. This promotes lipolysis (fat breakdown) particularly in visceral fat deposits while preserving lean muscle mass.
Tesamorelin is given as a single daily subcutaneous injection — usually in the morning — on a provider-determined schedule.
Tesamorelin binds GHRH receptors in the pituitary gland, triggering the natural release of growth hormone. That promotes lipolysis (fat breakdown) particularly in visceral fat deposits, while preserving subcutaneous fat and lean muscle mass.
Over the following weeks most people notice small energy and sleep changes first (weeks 1–2), then a looser waistband and better recovery (weeks 3–6), then measurable waist-circumference reduction and improved bloodwork (weeks 6–12). Your provider may check IGF-1 along the way.
What the research shows
15%
Visceral fat reduction over 26 weeks (Phase III)
FDA-approved
For HIV-associated lipodystrophy (Egrifta)
26 wks
Pivotal Phase III trial duration
2010
Year FDA approval was granted
Our medication is delivered from a state-licensed pharmacy in our network, right to your door when you need it.
Our pharmacies perform third-party testing through FDA and DEA registered labs to run quality control checks for every compounded lot. They test four key characteristics associated with quality and safety.
Performed on every batch to confirm the active ingredient is present at the labeled concentration. Your vial contains exactly what it should.
Tests for the presence of bacteria, fungi, and other microorganisms. Every batch is tested and must meet the requirements of USP 797.1.
Screens for bacterial endotoxins that can cause fever or adverse reactions. Every batch is tested and must not exceed the threshold limits defined in USP 85.
Assesses the acid/base balance to ensure minimal irritation upon injection and confirm the solution is within the correct range for subcutaneous administration.
What to expect
Week 1–2
What you may notice: Subtle energy improvements. Sleep quality may begin to shift. You may feel more rested in the morning without obvious changes yet.
What’s happening: GH levels are beginning to rise — your pituitary is responding to the GHRH signal and ramping up natural growth-hormone production.
Week 3–6
What you may notice: Clothes start fitting differently. The abdominal area feels tighter. Energy levels are more consistent through the day.
What’s happening: Active visceral fat reduction is underway with increased GH output. Your metabolism is shifting toward a more efficient baseline.
Week 6–12
What you may notice: Measurable reduction in waist circumference. Better muscle definition. Improved workout recovery.
What’s happening: Significant visceral fat reduction. Lipid profiles may show improvement. Body-composition changes become clearly visible.
Week 12+
What you may notice: Full body-composition benefits realized. Sustained metabolic improvement. Consistent energy and recovery.
What’s happening: Most people see their best results during this extended window — metabolic improvements are well-established and maintainable.
Comparison
Both raise growth hormone — here's which one fits.
| Tesamorelin | CJC-1295/Ipamorelin | |
|---|---|---|
| Best for | Visceral (belly) fat reduction and metabolic optimization | Broad GH support — body composition, sleep, recovery |
| How it works | A single, stabilized GHRH analog | Two pathways — a GHRH analog plus a selective GH secretagogue |
| FDA status | FDA-approved (for HIV-associated lipodystrophy) | Compounded — not FDA-approved |
| Best if you have | Stubborn abdominal fat or metabolic concerns | Multiple goals: fat loss, lean mass, sleep, anti-aging |
| Can combine? | Yes — pairs well with Ipamorelin | Yes — pairs well with Sermorelin |
What’s included
From the moment you finish your assessment to your first dose, every step is handled by licensed providers and U.S. pharmacies.
New to self-injection? See the step-by-step guideFAQ
Patient reviews
This is not medical advice. Every patient's experience differs and not everyone qualifies for peptide therapy. All reviews are from verified PeRx patients and are published as submitted. Peptide therapy requires a valid prescription from a licensed provider.
Your safety, first
All prescriptions are issued by a licensed US provider after reviewing your intake.
Side effects, contraindications, and what to discuss with your provider before starting.
Read safety informationSupporting research
A selection of peer-reviewed work on Tesamorelin. Browse the full literature on PubMed and Google Scholar for ongoing research.
Significant visceral fat reduction
Falutz J et al. J Clin Endocrinol Metab. 2004.Pivotal Phase III trial
Falutz J et al. N Engl J Med. 2007;357:2359–2370.Long-term metabolic effects
Stanley TL et al. HIV Med. 2018.The statements on this page have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The FDA does not review or approve compounded medications for safety or effectiveness. Off-label use must be prescribed and supervised by a licensed provider.
Keep exploring
Last updated April 2026
Medical disclaimer
The information provided on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Peptide therapy requires a valid prescription from a licensed healthcare provider. Individual results may vary. No specific outcomes are guaranteed.
The peptides on this site are not FDA-approved. They are compounded by licensed pharmacies under provider supervision. Certain peptides are prohibited by WADA and major sports organizations. Statements on this page have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
Take our 2-minute assessment. A licensed US provider reviews and, if appropriate, prescribes a protocol shipped to your door.
$229 / month
Starting at $175/mo with 3-month supply + WELCOME10
